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Smad genes are recently identi®ed intracellular effectors for receptor signaling in the BMP/activin/TGF-b pathway. Since
TGF-b ligands are known to inhibit embryonic lung branching morphogenesis, we tested the hypothesis that Smad genes
negatively regulate lung organogenesis. Antisense oligodeoxynucleotides were designed to attenuate Smad3 and Smad2
gene expression in embryonic (E11) mouse lungs over 4 days in culture. Endogenous Smad3 and Smad2 mRNA levels were
suppressed by 97 and 91%, respectively, in cultured embryonic lungs when antisense oligodeoxynucleotide (40 mM) to
Smad was added, compared to scrambled and sense sequence controls. The corresponding Smad3 and Smad2 protein
amounts were also decreased respectively by 86 and 90% in lungs treated with Smad3 and Smad2 antisense oligodeoxy-
nucleotide. Phenotypically, Smad antisense oligodeoxynucleotides resulted in a concentration-dependent increase in lung
branching: embryonic lung branching was stimulated by up to 53% in culture with 40 mM antisense oligodeoxynucleotide,
whereas both scrambled and sense controls showed no stimulatory effect. Thus, inhibition of endogenous Smad3 and
Smad2 gene expression resulted in stimulation of embryonic lung branching similar to that caused by inhibition of TGF-
b type II receptor expression and signaling (J. Zhao et al., 1996, Dev. Biol. 180, 242±257). Abrogation of Smad4 (DPC4),
the downstream mediator of Smad3 and Smad2 proteins, with antisense oligodeoxynucleotide, also resulted in increased
branching morphogenesis. Furthermore, while TGF-b alone inhibited lung branching morphogenesis in culture, addition
of exogenous TGF-b1 could not overcome the stimulatory effect on lung branching of Smad antisense oligodeoxynucleotide
treatment. By immunohistochemistry, Smad proteins were localized mainly to the epithelial cells lining the branching
distal airways, indicating that Smad genes could regulate lung morphogenesis through mesoderm±endoderm interaction.
Our results demonstrate, for the ®rst time, that abrogation of Smad2 and Smad3 or of Smad4 gene expression stimulated
early mouse embryonic lung branching morphogenesis in culture, possibly through reversing the negative in¯uence of
endogenous TGF-b signaling upon lung branching morphogenesis. q 1998 Academic Press
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INTRODUCTION ferentiation (reviewed by Hilfer, 1996). Secreted signaling
molecules such as transforming growth factor-b (TGF-b)
Epithelial±mesenchymal interactions have been impli- family peptides regulate cell growth, differentiation, and
cated in branching morphogenesis of embryonic lung. Lung tissue morphogenesis through autocrine/paracrine signal-
development begins with the outgrowth of paired lung buds ing mechanisms. TGF-b induces growth arrest in various
from the foregut endoderm that invade the surrounding me- cell types, including lung epithelial cells, and expression of
sodermal mesenchyme in a genetically predetermined pat- a wide array of proteins, some of which are deposited in the
tern of branching morphogenesis and lung-speci®c cell dif- lung extracellular matrix.
TGF-b belongs to a superfamily including activin, bone
morphogenetic proteins (BMP), and TGF-b1, 2, and 3. TGF-1 To whom correspondence should be addressed at the USC Cen-
b ligands bind to TGF-b type II receptor and this triggerster for Craniofacial Molecular Biology, 2250 Alcazar Street, CSA
heteromerization with TGF-b type I receptors (MassagueÂ et103, Los Angeles, CA 90033. Fax: (213) 342-2981. E-mail: dwarbur
ton%smtpgate@chlais.usc.edu. al., 1990; Roberts et al., 1990). Following heteromerization,
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the TGF-b type II receptor serine/threonine kinase trans- hand, abrogation of TGF-b type II receptor expression and/
or signaling stimulated embryonic lung branching morpho-phosphorylates the type I receptor, resulting in the propaga-
tion of a phosphorylation signal to downstream substrates genesis in culture and prevented TGF-b-induced down-reg-
ulation of cyclin A expression (Zhao et al., 1996), indicating(Wrana et al., 1994).
Until recently, little was known about the signaling mol- that endogenous TGF-b also negatively regulates lung mor-
phogenesis. However, how intracellular effector proteins inecules and intracellular substrate proteins that mediate the
TGF-b type I/type II receptor heterocomplex responses to the TGF-b signaling pathway such as the Smads regulate
lung organogenesis remains to be elucidated. Therefore, toextracellular TGF-b ligand binding. Genetic studies in Dro-
sophila uncovered the mothers against dpp (mad) gene as investigate the functional role of Smad genes during embry-
onic lung branching morphogenesis, we designed antisensea maternal effector that constitutes a downstream compo-
nent for signaling by decapentaplegic (dpp), the fruit¯y ho- oligodeoxynucleotides (ODN) to attenuate Smad gene ex-
pression as a loss-of-function strategy. Due to extremelymologue of mammalian BMPs (Raftery et al., 1995; Sekel-
sky et al., 1995). Overexpression of Mad protein was found high homology between mammalian Smad3 and Smad2
(Zhang et al., 1996), the antisense ODN used in the currentto complement Dpp de®ciency, while Dpp failed to induce
biological responses in Mad-mutant ¯ies (Wiersforff et al., study was able to ef®ciently inhibit both Smad3 and Smad2
gene expression. We found that abrogation of Smad3 and1996; Newfeld et al., 1996). Three Sma2, Sma3, and Sma4
proteins structurally related to Drosophila Mad were also Smad2 or of Smad4 gene expression resulted in signi®cant
stimulation of embryonic mouse lung branching morpho-found in parallel studies of Caenorhabditis elegans develop-
ment (Savage et al., 1996). These intracellular proteins are genesis in culture.
required for the function of Daf-4, a serine/threonine kinase
receptor which responds to C. elegans homologues of BMP-
2 and BMP-4 (Estevez et al., 1993). MATERIALS AND METHODS
Nine vertebrate Mad gene counterparts have been identi-
®ed and are referred to as Smad1 through Smad8 (Derynck Organ culture. Timed-pregnant Swiss±Webster mice were sac-
et al., 1996; Chen et al., 1997; Nakao et al., 1997; Suzuki ri®ced on postcoitum day 11 (E11) and the embryos were removed.
et al., 1997; Topper et al., 1997). All the Smad proteins Lung primordia in early pseudoglandular stage were isolated from
embryos by microdissection using micro-ophthalmic surgical in-share two highly conserved amino- and carboxy-terminal
struments and a dissecting microscope under sterile conditions.domains separated by a more diverse proline-rich region
Embryonic lungs were cultured under serum-free, chemically de-(Derynck and Zhang, 1996). Further studies reveal a selec-
®ned conditions as reported previously (Warburton et al., 1992;tivity in different Smad proteins to mediate distinct re-
Zhao et al., 1996). E11 lung explants were placed on 0.80-mm MF-sponses to receptor signaling. Smad1 (also previously re-
Millipore ®lters (Millipore, Bedford, MA) supported by stainlessferred to as Madr1 and Dwar®n-A) is the intracellular ef-
steel grids in Grobstein culture dishes (Falcon, Lincoln Park, NJ)
fector for BMP-2/-4 signaling (Liu et al., 1996; Hoodless et and cultured in BGJb medium (Gibco, Grand Island, NY) supple-
al., 1996; Yingling et al., 1996; Kretzschmar et al., 1997). mented with 0.1 mg/ml ascorbic acid and 50 units/ml penicillin/
Smad2 (also previously referred to as Madr2 and JV18-1) streptomycin. About 900 ml medium was added to each dish (ap-
appears to respond to both activin and TGF-b (Zhang et proximately 10 explants per dish) to establish an air±¯uid interface
at the level of the explants. The cultures were maintained in 100%al., 1996). Smad2 is phosphorylated by the TGF-b receptor
humidity with an atmosphere of 95% air and 5% CO2 for 4 days.complex (MacõB as-Silva et al., 1996). Overexpression of
The medium was changed every 2 days.Smad3 induces strong ligand-independent TGF-b-like activ-
Quanti®cation of terminal branches. Branching morphogene-ity, while a truncated Smad3 mutant acts as a dominant
sis was expressed as the number of epithelial sacs visible aroundnegative inhibitor of the natural TGF-b response (Zhang et
the periphery of the lung explants. The analyses were performedal., 1996), which strongly indicates that Smad3 is a key
(i) on whole mounts of lung explants, using transillumination to
intracellular mediator in the TGF-b signaling pathway. On visualize structures and photomicrography to record permanent
the other hand, Smad4 (DPC4) binds to and thus cooperates images, and (ii) on paraf®n histological sections of ®xed material.
synergistically with Smad1, Smad2, or Smad3 to serve as a In either case, both lungs were counted.
common mediator in the BMP, activin, and TGF-b signaling Smad antisense oligodeoxynucleotide inhibition. Smad anti-
sense ODN was designed to surround the translational initiationpathways, respectively (Lagna et al., 1996; de Caestecker et
site, a place known empirically to be most effective for inhibitional., 1997; Zhang et al., 1997).
of gene expression. Smad antisense ODN 5*GCAGGATGGACGA-Thus, it appears that the TGF-b signal can be transmitted
CAT3* was synthesized based on mammalian Smad3 (perfectvia receptor-associated Smad3 and/or Smad2 to their down-
match for both rat and human Smad3 cDNAs; Y. Chen et al., 1996;stream mediator Smad4, whereas Smad1 turns out to be
Zhang et al., 1996) and Smad2 (only one mismatch at underlinedinvolved in the BMP rather than the TGF-b signaling path-
nucleotide ``G'' for murine Smad2 cDNA; Baker and Harland, 1996).
way. Both exogenous TGF-b1 and TGF-b2 exert negative Two same-length control ODNs to Smad were also synthesized:
regulation on embryonic lung branching morphogenesis in (i) 5*GTGGACAGCTAGAGAC3* (same nucleotides but randomly
culture (Serra et al., 1994; Zhao et al., 1996), while TGF-b3 scrambled sequence) and (ii) 5*ATGTCGTCCATCCTGC3* (sense
null-mutant mice display an abnormal pattern of embryonic sequence).
For Smad4 (DPC4), antisense ODN 5*TAGACATATTGT-lung development (Kaartinen et al., 1995). On the other
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CCAT3* was designed based on the murine cDNA sequence (Ying- A260  50 mg/ml. Only 20 ng reverse-transcribed total RNA was
used in respective Smad competitive PCR. b-Actin competitiveling et al., 1996). Same-length scrambled and sense control ODNs
PCR as an internal control was performed on the same samplesfor Smad4 were also synthesized. The ®rst and last three bases
along with the above genes.on each ODN sequence were modi®ed by phosphorothioation to
Densitometric analysis. Electrophoresis was performed on 3%improve stability against nuclease degradation in culture. The
agarose gels (3:1 mixture of Nusieve and Seakem; FMC, Rockland,ODNs were puri®ed by OPC column before use (USC MicroCore
ME) in a submarine gel unit (C.B.S. Scienti®c Co., Del Mar, CA),Lab, Los Angeles, CA). Antisense, scrambled, and sense ODNs were
in which target and competitor PCR products were separated byadded to embryonic mouse lung culture in aqueous solution to
size. Gels were stained with 5 mg/ml ethidium bromide and photo-achieve ®nal concentrations of 20 or 40 mM.
graphed with Polaroid 667 ®lms. The intensity was determined bySmad competitive PCR. Smad genes are highly conserved and
densitometric analysis using ImageQuan band-analyzing softwareclose homology exists among species (Derynck and Zhang, 1996).
(Molecular Dynamics, Sunnyvale, CA). Calculation and statisticalA cDNA fragment of murine Smad3 was obtained from reverse-
analysis were performed using Microsoft Excel 5.0. A P  0.05 wastranscribed embryonic lung total RNA by degenerate PCR and sub-
accepted as statistically signi®cant. All the organ culture experi-sequently sequenced. This murine Smad3 fragment has about 95%
ments in the present study were repeated at least three times, withnucleotide sequence homology to either rat or human Smad3 (Zhao
identical results obtained.and Warburton, unpublished data). Thus, a pair of PCR primers was
Immunohistochemistry. Cultured lung explants were ®xedsynthesized based on the murine Smad3 cDNA sequence: primer 1
with paraformaldehyde upon harvest and subsequently embedded(upstream), 5*GAGTAGAGACGCCAGTTCTACC3*, and primer
into paraf®n. Embryonic lung sections (5 mm thick) on poly-L-ly-2 (downstream), 5*GGTTTGGAGAACCTGCGTCCAT3*. When
sine-coated slides were used for immunohistochemical study.primers 1 and 2 were used, the resultant PCR product from reverse-
Smad antibody (goat polyclonal IgG; Santa Cruz Biotechnologies)transcribed embryonic mouse lung total RNA was 234 bp in length.
was used at a concentration of 10 mg/ml for Smad protein immuno-Construction of Smad3 competitor was done as described pre-
staining. Biotinylated second antibody and streptavidin±peroxidaseviously (Zhao et al., 1996). Brie¯y, two composite primers were
conjugate were used to detect bound antibody. Subsequent additionused for Smad3 competitor construction (Fig. 3): each composite
of aminoethyl carbazole chromogen generated a reddish precipitateprimer had the target Smad3 gene primer sequence (black box)
surrounding the Smad antigen (Zymed, South San Francisco, CA).attached to a short stretch of sequence (hatched box) designed to
Three negative controls were run in parallel with Smad antibodyhybridize to opposite strands of a heterogeneous DNA fragment.
to ensure speci®city: (1) polyclonal IgG preabsorbed with blockingThe desired primer sequences were thus incorporated into the het-
peptide, (2) bovine serum albumin, and (3) water control.erogeneous fragment during the PCR. This ensured that all Smad3
Western analysis. Individual lung explants were harvestedcompetitor molecules had the same gene-speci®c primer sequences
after culture and placed in a lysis buffer containing 1.0% Tritonas the Smad3 cDNA. The heterogeneous DNA was derived from a
X-100, 0.5% NP-40, and protease inhibitors. The total protein con-piece of v-erbB DNA. Smad3 competitor using primers 1 and 2 is
centration in each lung sample was determined using the Micro344 bp in length. The identities of the Smad3 and its competitor
BCA Protein Assay Reagent kit (Pierce, Rockland, IL). Fifty micro-were both con®rmed by DNA sequencing, proving that they both
grams of total protein from each sample was electrophoresed on autilize the same set of PCR primers (Sanger et al., 1977).
7.5% Tris±Glycine polyacrylamide gel. Protein on the gel was thenRNA extraction and reverse transcription. Total RNA from
transferred to a Millipore Immobilon-P membrane by using a Bio-each individual cultured lung explant was extracted by guanidi-
Rad Mini Trans-Blot electrophoretic transfer cell. Equal transfernium thiocyanate following homogenization utilizing the Total
ef®ciency for each sample was con®rmed by Coomassie blue stainRNA Isolation kit from 5*Prime±3*Prime (West Chester, PA). Ex-
of the membrane after Western blot. The subsequent Western blottracted total RNA was reverse transcribed as described previously
was performed utilizing the Chemiluminescence Western Blotting(Zhao et al., 1995). Samples were incubated at 377C for 1 h in 20
kit (Boehringer Mannheim, Indianapolis, IN). A ®nal concentration
ml of 10 mM Tris (pH 8.4), 50 mM KCl, 2 mM MgCl2, 1 mM of 200 ng/ml Smad antibody (goat polyclonal IgG; Santa Cruz Bio-
dithiothreitol, 5 units ribonuclease inhibitor, 0.5 mM dNTP, 100
technologies) was incubated with the membrane at 47C overnight.
pmol oligo(dT)12±18 , and 200 units M-MLV reverse transcriptase POD (horseradish peroxidase)-labeled secondary antibody was
(USB, Cleveland, OH). The reaction was terminated by heating for
added to incubate with the membrane for 1 h. The chemilumines-
5 min at 957C. Reverse-transcribed products were then used for
cent light was captured by Kodak X-Omat AR ®lm for a permanent
competitive PCR assay.
record.
Competitive PCR ampli®cation was carried out in a Robocycler
(Stratagene, La Jolla, CA) using a modi®cation of a previously de-
scribed assay for TGF-b type II receptor (Zhao et al., 1996). Thirty-
RESULTS®ve cycles of denaturation at 947C for 2 min, annealing at 627C for
2 min, and extension at 727C for 2 min were routinely performed
after an initial 3-min denaturation at 947C. The ®nal cycle included Antisense ODN to Smad3 and Smad2 stimulated embry-
a 5-min extension step. The reaction mixture contained 10 mM onic mouse lung branching morphogenesis in culture.
Tris (pH 9.4), 50 mM KCl, 2 mM MgCl2 (optimized), 0.01% gelatin, E11 lung explants (Fig. 1A) underwent extensive branching
0.1% Triton X-100, 20 pmol primer sets, 100 mM dNTP, and 0.5
morphogenesis in BGJb media and displayed a characteristicunit Advantage Klentech DNA polymerase (Clontech, Palo Alto,
branched pattern (Fig. 1B) after 4 days in culture. A clearCA). Reaction mixture containing a known amount of competitor
stimulation of lung branching was observed when antisensewas added to reverse-transcribed samples derived from 20 ng total
ODN to Smad3 and Smad2 genes at both 20 and 40 mM wasRNA or to dilutions of standard cDNA templates in a total volume
added directly to culture media (Figs. 1D and 1F), whereasof 50 ml. Concentrations of cDNA standard solutions were deter-
mined spectrophotometrically upon absorbance at 260 nm using 1 parallel experiments with scrambled (Figs. 1C and 1E) or
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sense (not shown) ODN to Smad3 and Smad2 did not show
any stimulatory effect. After quanti®cation of terminal
branches, Smad3 and Smad2 antisense ODN-treated lung
explants resulted in a concentration-dependent stimulation
on branching morphogenesis (Fig. 2, left): antisense ODN
to Smad3 and Smad2 increased embryonic lung branching
morphogenesis by 24 or 53% at 20 or 40 mM, respectively
(P  0.05). However, both scrambled control ODN (105 or
109% of media control at 20 or 40 mM, respectively) and
sense control ODN to Smad3 and Smad2 (105 or 95% of
media control at 20 or 40 mM, respectively) resulted in un-
changed levels of lung branching morphogenesis in compar-
ison to media control (Fig. 2, left).
Measurement of Smad mRNA levels by competitive RT-
PCR. To evaluate the consequences of Smad antisense
ODN treatment in cultured embryonic lung, a highly sensi-
tive and accurate assay to measure speci®c Smad mRNA
amount was developed based on competitive RT-PCR
methodology. For Smad3, the same pair of PCR primers was
designed and used for ampli®cation of both Smad3 cDNA
and Smad3 competitor (Fig. 3A) as described under Materi-
als and Methods. When a constant amount of Smad3 com-
petitor was used to coamplify with a 1:2 dilutional series
of Smad3 cDNA, an electrophoretic pattern showing an in-
verse relationship in band intensities between Smad3
cDNA and its competitor was obtained (Fig. 3B). Thus, the
ratio of Smad3 cDNA to Smad3 competitor PCR products
re¯ected the initial amounts of Smad3 cDNA and Smad3
competitor included in the competitive PCR ampli®cation.
Following densitometric scanning, a regression line (R2 
0.95) for Smad3 competitive PCR was acquired by plotting
the logarithm of band intensities of Smad3 cDNA over its
competitor against the initial amounts of Smad3 cDNA
added in the Smad3 competitive PCR (Fig. 3C, open circles).
In the next step, different amounts of reverse-transcribed
total RNA from cultured embryonic lungs were used to
coamplify with the same amount of Smad3 competitor, and
a similar regression line (R2  0.95) with the same slope
value was obtained (Fig. 3C, closed circles). The same slope
values as above indicated that recombinant Smad3 behaved
identically to the Smad3 cDNA derived from reverse-tran-
scribed products. Thus, it is possible to accurately measure
Smad3 mRNA levels as its cDNA equivalent using the lin-
ear equation derived from recombinant Smad3 standards.FIG. 1. Smad gene expression modulated embryonic murine
The detection limit for Smad3 competitive RT-PCR islung branching morphogenesis. E11 embryonic mouse lung dis-
0.0625 fg Smad3 cDNA or 10 ng reverse-transcribed totalsected from embryo (A) underwent branching morphogenesis to
develop a characteristic branching pattern (B) after 4 days in RNA (Fig. 3C).
BGJb medium culture. While antisense ODN to Smad3 and Competitive PCR methodology was developed for other
Smad2 at 20 or 40 mM demonstrated a concentration-dependent murine Smad mRNA quanti®cation, including Smad1,
stimulation of lung branching morphogenesis (D and F), scram- Smad2, and Smad4 (DPC4), in embryonic mouse lung, using
bled ODN to Smad3 and Smad2 at the same concentrations a similar strategy as for Smad3 (standard curve not shown).
showed no effect (C for 20 mM and E for 40 mM). The stimulatory
Because of high homology between mammalian Smad geneseffect on branching could not be overcome by addition of exoge-
(especially between Smad3 and Smad2, 95%), PCR prim-nous TGF-b1 in the presence of Smad antisense ODN (H), while
ers were carefully chosen and resultant PCR products werecoadministration of both Smad scrambled ODN and TGF-b1
resulted in inhibition of branching morphogenesis (G). Bar rep- sequenced or digested with restriction enzymes to ensure
resents 150 mm. speci®city.
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FIG. 2. Antisense ODN to Smad3 and Smad2 or to Smad4 (DPC4) gene stimulated embryonic mouse lung branching morphogenesis in
a concentration-dependent manner. E11 lung explants were cultured in media control (MC), scrambled (SR), sense, (SE), or antisense ODN
to Smad3 and Smad2 (left) or Smad4 (middle) for 4 days and the number of terminal branches were quantitated after culture. Error bars
indicate standard deviation from at least 10 lungs for each assayed condition. While two control ODNs (SR and SE) yielded numbers of
terminal branches at both 20 and 40 mM similar to those of MC, antisense ODN to Smad3 and Smad2 resulted in a concentration-
dependent stimulation of embryonic lung terminal branches (124 and 153% compared to MC at 20 and 40 mM, respectively). A similar
dose-dependent stimulation of branching morphogenesis was also observed when antisense ODN to Smad4 was used in embryonic lung
explant culture (middle). When antisense ODNs to both Smad3 or Smad2 and Smad4 were used at 40 mM in lung explant culture, branching
morphogenesis was increased by 59% (right).
Attenuation of endogenous Smad gene expression by abrogated endogenous Smad3 gene expression in embryonic
mouse lung culture, but also negatively regulated endoge-antisense ODN in embryonic mouse lung culture. Embry-
onic lungs were extracted for total RNA after culture, and nous Smad2 mRNA levels in the same assayed lung samples
(Fig. 4A). Similar to Smad3 inhibition, Smad3 and Smad2reverse-transcribed total RNA was then subjected to com-
petitive PCR assay for both Smad3 and Smad2 mRNA deter- antisense ODN attenuated endogenous Smad2 gene in a
dose-dependent fashion: 20 and 40 mM antisense ODN tomination. Embryonic lungs cultured in various concentra-
tions (20 and 40 mM) of scrambled and sense control ODNs Smad3 and Smad2 signi®cantly down-regulated Smad2
mRNA levels to 64 and 9%, respectively, in comparison toto Smad3 and Smad2 yielded amounts of Smad3 mRNA
comparable to media control, as shown by Smad3 competi- media control (Fig. 4B). Thus, the Smad3 and Smad2 anti-
sense ODN we used in the current study was able to ef®-tive PCR electrophoretic pattern (Fig. 4A). In contrast, lungs
treated with antisense ODN to Smad3 and Smad2 showed ciently and simultaneously inhibit mRNA expression of
both Smad3 and Smad2 genes.decreased amounts of endogenous Smad3 mRNA, indicat-
ing that Smad3 and Smad2 antisense ODN, not scrambled Although antisense ODN to Smad3 and Smad2 attenu-
ated both Smad3 and Smad2 mRNA levels in the embryonicor sense control ODN, ef®ciently inhibited Smad3 gene ex-
pression. Due to the high linearity of Smad3 competitive lung culture, endogenous Smad1 and Smad4 levels were
unaffected by Smad3 and Smad2 antisense ODN (Fig. 4A),PCR standard curve (Fig. 3), amounts of Smad3 mRNA in
different samples can be visually compared based on the indicating that Smad3/2 antisense ODN only inhibited
Smad3 and Smad2 gene expression with high ef®ciency andelectrophoretic pattern (Fig. 4A). However, accurate mea-
surement was obtained after densitometric analysis and speci®city. Thus, the observed stimulation of embryonic
lung branching morphogenesis could be attributed to thesubsequent calculation (Fig. 4B, left). Antisense ODN to
Smad3 and Smad2 inhibited endogenous Smad3 mRNA lev- abrogation of Smad3 and Smad2, but not Smad1 and Smad4,
gene expression.els in a dose-dependent manner, 20 mM Smad antisense
ODN decreased Smad3 mRNA levels by 41%, and 40 mM Abrogation of Smad4 (DPC4) gene expression also re-
sulted in increased embryonic lung branching morphogen-to a remnant 3% of basal level (P  0.05). In contrast, none
of the control ODN (scrambled and sense) to Smad3 and esis. The downstream effector protein for Smad3 and
Smad2 signaling in the activin/TGF-b pathway was alsoSmad2 at either of the above concentrations signi®cantly
changed Smad3 mRNA levels in cultured lungs. tested for its role during embryonic lung organogenesis.
While both scrambled and sense ODN to Smad4 did notSmad3 and Smad2 antisense ODN not only ef®ciently
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FIG. 3. Competitive RT-PCR for Smad3 mRNA measurement. (A) The same pair of primers (primers 1 and 2, black boxes) were used
for ampli®cation of both Smad3 cDNA and its competitor, and the resultant PCR products were 234 and 344 bp in length, respectively.
(B) A constant amount of Smad3 competitor (1 fg) was coampli®ed with a dilutional series of Smad3 cDNA (lanes 1 to 10: 0, 0.0625,
0.125, 0.25, 0.5, 1, 2, 4, 8, and 16 fg) and the resultant electrophoretic pattern showed a reverse relationship of intensities between Smad3
cDNA and its competitor bands. (C) The initial amount of Smad3 cDNA was plotted against the logarithm of (Smad3/competitor) after
densitometric scanning of both Smad3 and its competitor band intensities. A linear regression line (open circles) was thus obtained. A
similar regression line with identical slope value was also obtained (closed circles) when different amounts of reverse-transcribed products
from embryonic lung replaced Smad3 cDNA in Smad3 competitive PCR. Both regression lines have coef®cient factor values (R2) greater
than 0.95.
change lung branching, antisense ODN to Smad4 led to effect on Smad4 mRNA expression. Additionally, while
Smad4 antisense ODN ef®ciently inhibits Smad4 gene ex-stimulation of embryonic lung branching morphogenesis
(Fig. 2, center). As determined by the number of terminal pression, other Smad gene expression, including Smad1,
Smad2, and Smad3, remained unchanged regardless ofbranches, antisense ODN to Smad4 increased embryonic
lung branching by 19 and 33% at 20 and 40 mM, respectively Smad4 antisense treatment on embryonic lung explant in
culture (Fig. 6A). Therefore, the observed stimulatory effect(P  0.05), while neither scrambled nor sense ODN to
Smad4 showed any signi®cant change in lung branching upon lung branching morphogenesis with Smad4 antisense-
treatment resulted from abrogation of Smad4, not Smad1,morphogenesis in culture (Fig. 2, center). Thus, Smad4 anti-
sense ODN stimulated embryonic branching morphogene- Smad2, or Smad3, gene expression.
Since abrogation of either Smad3/Smad2 or Smad4 re-sis in cultured lungs in a concentration-dependent manner,
similar to that of antisense ODN to Smad3 and Smad2. sulted in similar stimulation of embryonic lung branching,
the combined effects of simultaneous inhibition of bothSpeci®city of Smad4 antisense ODN was con®rmed by
competitive PCR quanti®cation of Smad4 mRNA level in Smad3/Smad2 and Smad4 were subsequently studied by
antisense ODN inhibitory strategy. While either Smad3/cultured embryonic lungs. As shown in Fig. 6, antisense
ODN to Smad4 ef®ciently attenuated Smad4 mRNA ex- Smad2 or Smad4 antisense ODN alone (40 mM) resulted in
respective 53 and 33% increase of lung branching, coadmin-pression: 20 mM Smad4 antisense ODN decreased Smad4
mRNA to 58% and 40 mM antisense ODN to Smad4 re- istration of both Smad3/Smad2 and Smad4 antisense ODNs
(40 mM) stimulated embryonic lung branching morphogene-duced Smad4 mRNA level in cultured embryonic lung to a
remnant 10% in comparison to media control. However, sis by 56%, comparable to that of either Smad3/Smad2 or
Smad4 alone (P  0.05) (Fig. 2, right). Such a lack of syner-both scrambled and sense ODN to Smad4 had no inhibitory
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FIG. 4. Inhibition of Smad3 and Smad2 gene mRNA by antisense ODN. (A) As shown by competitive PCR electrophoretic pattern,
embryonic mouse lung explants exposed to media control (MC) or scrambled (SR) or sense (SE) ODN to Smad3 and Smad2 gene at both
20 and 40 mM yielded comparable amounts of both Smad3 and Smad2 mRNA. In contrast, lungs treated with Smad antisense (AS) ODN
to Smad3 and Smad2 at above concentrations resulted in reduction of both Smad3 and Smad2 mRNA levels. (B) Quanti®cation of both
Smad3 and Smad2 mRNA levels after densitometric scanning showed a dose-dependent inhibition of both Smad3 and Smad2 mRNA by
antisense ODN, while both Smad3 and Smad2 mRNA amounts in controls (media control and scrambled and sense ODN) remained
unchanged. Antisense ODN to Smad3 and Smad2 showed no inhibitory effect on either Smad1 or Smad4/DPC4 mRNA level. Although
only one typical lung was shown in each electrophoretic pattern, error bars (B) represent standard deviations from at least six lungs for
each experimental condition.
gistic effect on lung branching stimulation when both b1 reduced lung branching by 30% in plain media or by
26% in 40 mM Smad3 and Smad2 scrambled ODN (Fig. 5,Smad3/Smad2 and Smad4 were simultaneously inhibited
con®rmed that these Smad genes function through an iden- open bars). A similar inhibitory effect was also observed
when Smad3 and Smad2 control ODN was substituted withtical signaling pathway during lung organogenesis. That is,
the observed stimulation of lung branching by antisense Smad4 control ODN in the presence of TGF-b1: TGF-b1
decreased lung branching morphogenesis by 31% in theODN to either Smad3/Smad2 or Smad4 is due to blockade
of the TGF-b signaling. presence of 40 mM scrambled ODN to Smad4 (closed bars).
However, such an inhibitory effect was abolished whenStimulatory effect on lung branching morphogenesis by
Smad antisense ODN was not overridden by exogenous antisense ODN to either Smad3 and Smad2 or Smad4 re-
placed respective scrambled control ODN in lung cultureTGF-b. To further test the effect of abrogation of Smad
genes on branching, embryonic lungs in culture were media. Stimulation of lung branching was observed in the
presence of Smad antisense ODN, regardless of exogenouslytreated with exogenous TGF-b1 in the presence of Smad
antisense ODN. Previous studies have shown that TGF-b1 added TGF-b1 (Fig. 5). While 40 mM antisense ODN to
Smad3 and Smad2 increased lung branching by 48%, a com-ligand decreases embryonic lung branching morphogenesis
in a dose-dependent fashion (Serra et al., 1994; Zhao et al., parable 41% elevation was still observed when exogenous
TGF-b1 was added in addition to antisense ODN (open1996). Herein, 10 ng/ml TGF-b1 showed an inhibitory effect
on lung branching in the presence of 40 mM scrambled (Fig. bars). A similar refractoriness to exogenous TGF-b1-in-
duced lung branching inhibition was also obtained when1G) or sense (not shown) control ODN to Smad3 and Smad2.
When terminal branches were quantitated, 10 ng/ml TGF- antisense ODN to Smad4 was used: A 30% stimulation of
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plasm suggests that Smad proteins participate in epithelial±
mesenchymal interaction. For Smad1, Smad2, and Smad3,
proteins were exclusively detected in the distal epithelium,
whereas immunostaining was absent in the pulmonary
mesenchyme (Figs. 7A±7D). However, Smad4 (DPC4) stain-
ing was observed in both lung distal epithelial and stromal
cells, although lesser staining was found in mesenchyme
(Fig. 7F). Like the other Smads, Smad4 protein was not found
in proximal epithelial cells (Fig. 7F, arrow). Therefore, Smad
proteins overlap as well as distinguish from each other in
their localization pattern, indicating that they may function
in a cooperative manner in the same cells as well as possibly
having distinct functions in different cell populations dur-FIG. 5. Exogenous TGF-b could not reverse the Smad antisense
ing embryonic lung branching morphogenesis.ODN-induced stimulatory effect on lung branching morphogene-
Antisense ODN also decreased Smad protein levels insis. While 10 ng/ml exogenously added TGF-b1 decreased terminal
cultured lungs. Western analysis was used to con®rm thebranches in cultured embryonic mouse lung either in plain media
speci®city of Smad antibodies and the reduction of Smador in the presence of 40 mM scrambled (SR) ODN to Smad, the
effect of increased terminal branches by antisense (AS) ODN to protein levels with Smad antisense ODN administration.
Smad3 and Smad2 (open bars) or Smad4 (DPC4) (closed bars) was As shown in Fig. 8A, cultured lungs treated with Smad3/
observed regardless of exogenous TGF-b1 in the culture media. Smad2 antisense ODN showed decreased levels of both
Standard deviation was derived from at least 10 lungs. Smad3 and Smad2 proteins in comparison to lungs with
scrambled ODN treatment, while Smad4 protein amounts
in cultured lungs remained unchanged with Smad3/Smad2
ODN administration (Fig. 8A, left). On the other hand, anti-branching remained, regardless of exogenously added TGF-
b1 in embryonic lung culture treated with Smad4 antisense sense to Smad4 speci®cally reduced only Smad4 protein,
not Smad3 or Smad2 protein amounts, in embryonic lungsODN (closed bars). The above ®ndings indicate that TGF-
b failed to exert its negative effect on lung branching mor- in culture (Fig. 8A, right). Smad1 protein levels in lungs
were not signi®cantly altered regardless of Smad2, Smad3,phogenesis when the TGF-b signaling pathway was blocked
by abrogation of Smad3 and Smad2 or their downstream or Smad4 ODN treatment (data not shown). After densito-
metric analysis, Smad2, Smad3, or Smad4 protein levelsSmad4 gene expression.
Smad proteins were localized primarily to distal epithe- were respectively decreased to only 14, 10, or 11% (P 
0.05) of media control levels with Smad antisense ODNlium in embryonic murine lung. To further test the hy-
pothesis that Smad gene expression is involved in regulating treatment (40 mM), while either scrambled or sense Smad
ODN at the same concentration did not have any inhibitoryendoderm±mesoderm interaction during embryonic mouse
lung branching morphogenesis, different Smad proteins effect on Smad protein levels (Fig. 8B). Therefore, only the
antisense Smad ODN, not the scrambled or the sense Smadwere localized in cultured embryonic lungs by immuno-
staining. Smad1 protein, the intracellular effector for BMP ODN, resulted in a signi®cant reduction in the correspond-
ing Smad protein level, while other Smad protein amountspathway, was primarily detected in the distal epithelial cells
(Fig. 7A, arrowheads), while proximal epithelium was free were not changed.
Speci®city of Smad proteins was established: each Smadof Smad1 staining (arrow). Under high power, Smad1 protein
localized at highest intensity in epithelial cells lining the antibody recognized the band corresponding to the pre-
dicted size of the respective Smad protein on Western blottips of branching bronchi (Fig. 7B, arrowheads), which is
reminiscent of BMP localization pattern by whole-mount using lysis of cultured embryonic lungs treated with Smad
ODN. In the parallel control experiments, similar Westernin situ hybridization (Bellusci et al., 1996). Both Smad2 (Fig.
7C) and Smad3 (Fig. 7D) were localized to the epithelial results were obtained using Smad antibody with either em-
bryonic lung primary mesenchymal cells or NIH 3T3 cellscells in the distal airways, especially in terminal bronchial
epithelium undergoing branching. However, little or no (data not shown), con®rming the speci®city of Smad anti-
bodies used in the current study. Additionally, these spe-Smad2 and Smad3 staining was detected in pulmonary mes-
enchyme. The overlapping pattern of Smad2 and Smad3 ci®c Smad protein bands were diminished when Smad anti-
bodies were preabsorbed with respective control peptidesprotein localization indicates that Smad2 and Smad3 may
have or share similar functions during embryonic lung mor- prior to Western analysis.
phogenesis. Based on the immunostaining results, all the
Smad proteins we tested were primarily detected in cyto-
plasm of epithelial cells and were concentrated along the DISCUSSION
mesenchymal side of the cytosol, while relatively less stain-
ing was found on the lumenal side of cytoplasm (Figs. 7A± Morphogenetic autocrine/paracrine interactions between
mesenchymal and epithelial cells, as well as cell±matrix7D). Such a polar distribution of Smad proteins in cyto-
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FIG. 6. Antisense ODN to Smad4 (DPC4) decreased its mRNA level. Smad4 mRNA expression was inhibited in a dose-dependent manner
by antisense ODN to Smad4 at both 20 and 40 mM in cultured embryonic lungs, while either scrambled or sense control ODN at the
same concentrations did not affect Smad4 gene expression. (A) Smad4 antisense ODN failed to change Smad1, Smad2, or Smad3 mRNA
expression. (B) Error bars represent standard deviation from at least 10 lung explants for each assayed condition, although one lung was
shown in each electrophoretic pattern (A).
interactions, are implicated in the morphogenesis of signaling domains, such as the TGF-b receptors, are inhibi-
tory (Serra et al., 1994; Zhao et al., 1996).branched mammalian organs, including lung, kidney,
breast, pancreas, prostate, salivary gland, and sweat glands, Overexpression of Smad genes provided genetic evidence
that Smads are effector proteins in BMP/activin/TGF-b re-as well as tooth buds. Early embryonic lung develops at
E9.5 in the mouse as an endodermal appendage of the ante- ceptor signaling and that different Smads induce distinct
biological activities. Microinjection of Smad1 into Xenopusroventral pharynx, which extends into the surrounding
mesenchyme in a process termed branching morphogenesis. embryo mimics mesoderm ventralizing effects of BMP-4
(Liu et al., 1996). Smad1 moves to the nucleus from theMesenchymal recombination studies have demonstrated
that peripheral embryonic lung mesenchyme can induce cytoplasm when BMP-4 is expressed. BMP-2, not TGF-b or
activin, resulted in Smad1 phosphorylation (Hoodless et al.,ectopic branching as well as concomitant expression of pe-
ripheral lung-speci®c genes, when grafted adjacent to proxi- 1996). On the other hand, Smad2 is regulated by TGF-b,
not BMP, and missense mutations of Smad2 are not onlymal lung epithelium in embryonic lung in culture, and that
this effect is mediated by soluble and diffusible factors inactive, but also are found in colorectal carcinoma (Eppert
et al., 1996). TGF-b stimulates the phosphorylation and nu-(Alescio and Cassini, 1962; Shannon, 1994).
A number of soluble peptide growth factors are potential clear translocation of Smad2 in Mv1Lu cells (Nakao et al.,
1997). Smad2 transiently interacts with and is directly phos-mediators instructing primitive lung epithelial branching
morphogenesis. In general, the peptide growth factors that phorylated by the TGF-b receptor complex on C-terminal
serines. The latter phosphorylation requires activationactivate cognate receptors with tyrosine kinase intracellular
signaling domains such as EGFR, FGFR, c-met, IGFR, of TGF-b type I receptor by TGF-b type II receptor
(MacõB as-Silva et al., 1996). Mutation of these phosphoryla-KGFR, and PDGFR exert inductive or permissive in¯uences
on lung development (Warburton et al., 1992; Miettinen et tion sites generates a dominant negative Smad2 which
blocks TGF-b-dependent responses, while Smad2 fails toal., 1995, 1997; Souza et al., 1995; Shiratori et al., 1996),
while those cognate receptors with serine/threonine kinase accumulate in the nucleus in response to TGF-b signaling.
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FIG. 7. Immunohistochemistry of Smad protein in cultured embryonic lungs. Smad protein was localized by immunostaining in cultured
embryonic lung sections. (A) Smad1 protein was found primarily in distal epithelium, (B) especially in the epithelial cells lining the tips of
branching airway. Both (C) Smad2 and (D) Smad3 share a similar immunostaining pattern: their proteins were detected in epithelial cells along
the terminal bronchi. (E) Smad4 (DPC4) protein was found in both distal epithelial and mesenchymal cells, (F) while lung section incubated
with anti-IgG preabsorbed with blocking peptide (antigen) yielded negligible background. Magni®cation: A, 1001; C±F, 2001; B, 4001.
Overexpression of Smad2 functions as an activin-like meso- sponses can be recapitulated or inhibited by overexpressing
wild-type versus inactive Smads. C-terminal-truncatedderm inducer, and addition of activin enhances the concen-
tration of Smad2 in the nucleus (Baker and Harland, 1996). Smad3 acts as a dominant negative, overexpression of which
inhibits the natural TGF-b response (Zhang et al., 1996).Therefore, while Smad1 induces BMP-like responses,
Smad2 seems to be involved in transduction of activin/TGF- However, this inhibitory effect was not observed when
dominant negative Smad3 was substituted with either mu-b signaling.
It has also been shown that normal ligand-induced re- tant Smad1 or Smad2. Furthermore, overexpression of
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FIG. 8. Western analysis of Smad proteins for cultured embryonic lungs. (A) Antisense (AS) ODN to Smad3 and Smad2 reduced both
Smad3 and Smad2 protein levels relative to those of cultured embryonic lungs with scrambled (SR) ODN, while Smad4 protein amounts
did not change (left). Smad4 (DPC4) antisense ODN speci®cally decreased Smad4 protein level in comparison to scrambled ODN-treated
lungs, while both Smad3 and Smad 2 protein levels remained the same regardless of the addition of Smad4 ODN (right). (B) Densitometric
analysis subsequent to Western assay showed a greatly reduced level of Smad protein in cultured lungs with respective Smad antisense
ODN treatment, while both SR and sense (SE) ODN controls yielded levels of Smad proteins similar to those of the media control (MC).
Data are presented as means {SD.
Smad3 stimulated basal TGF-b-responsive transcriptional sion of other more divergent Smad genes, including Smad1
and Smad5 (data not shown), indicating that the antisenseactivity, whereas both basal and TGF-b-induced transcrip-
tional activity was inhibited when Smad1 was overex- ODN used in the current study speci®cally inhibited ex-
pression of Smad3 and Smad2 genes, but not other Smads.pressed (Y. Chen et al., 1996). Thus, Smad3 acts as an intra-
cellular effector of the TGF-b response, indicating a selec- In the current study, we were not able to differentiate
between the effects of inhibition of Smad3 and Smad2 genetivity in Smad activities and that different Smad proteins
mediate respectively BMP, activin, and TGF-b signaling expression using Smad antisense ODN, probably due to the
extremely high homology between mammalian Smad3 andpathways.
Both Smad3 and Smad2 are capable of responding to extra- Smad2 sequences. As a result, the observed stimulatory ef-
fect on lung branching morphogenesis by Smad antisensecellular TGF-b signals. Smad2 is phosphorylated upon asso-
ciation with the TGF-b receptor complex and mutation of ODN treatment could not be attributed speci®cally to
Smad2 or Smad3. Nevertheless, since both Smad3 andthe Smad2 phosphorylation sites functions as a dominant
negative, blocking TGF-b signaling (MacõB as-Silva et al., Smad2 function in the TGF-b signaling pathway, we feel
con®dent deducing that the stimulation of embryonic lung1996). However, overexpression of dominant negative
Smad3, but neither Smad1 nor Smad2, inhibited the TGF- branching we observed following abrogation of Smad2 and/
or Smad3 resulted from the release of endogenous TGF-b-b response (Zhang et al., 1996). While the intracellular in-
teractions between Smad3 and Smad2 remain to be clari®ed, mediated negative in¯uence on morphogenesis. Therefore,
our results further support that Smad2 and/or Smad3, notcomparison between Smad3 and Smad2 sequences revealed
that their proteins share 97% identity, suggesting that they other Smads, are the major intracellular effectors in re-
sponse to TGF-b signaling.may have very similar functions.
Because Smad3 and Smad2 are such closely homologous Smad3 and Smad2 are homologous yet distinct gene prod-
ucts. Thus, we were able to develop competitive PCR assaysproteins, we chose a Smad antisense ODN strategy in the
current study based on the mammalian Smad3 sequence for respective quantitation of Smad3 and Smad2 mRNA
levels. PCR primers were carefully chosen from the leastwhich has only one nucleotide mismatch with the corre-
sponding murine Smad2 cDNA. Consequently, our Smad homologous sequences to ensure speci®c ampli®cation of
either Smad3 or Smad2 gene (see Materials and Methods),antisense ODN was able to down-regulate both Smad3 and
Smad2 gene expression simultaneously. An alternative and subsequent PCR products were sequenced or digested
with appropriate restrictive enzymes to con®rm identities.Smad antisense ODN was designed based on the Smad2
sequence at its translational initiation site and thus had one Competitive PCR coupled with reverse transcription is an
accurate and highly sensitive method of measuring speci®cnucleotide mismatch with Smad3 cDNA. This alternative
Smad2 antisense ODN also displayed a strong inhibitory low-abundance gene message in limited sample material
(Zhao and Nishimoto, 1995). Using conventional hybridiza-effect on mRNA and protein expression of both Smad3 and
Smad2 genes (data not shown). However, while both of the tion methods like Northern blot, 10±50 mg total RNA is
routinely used for one mRNA determination (Siebert andabove Smad antisense ODNs ef®ciently attenuated Smad3
and Smad2 expression, they had little or no effect on expres- Larrick, 1992). However, as shown in our competitive PCR
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assay, only 20 ng total RNA was used to measure Smad3 cated into the nucleus to function as a transcriptional acti-
vator. How the Smad complex moves into the nucleus toor Smad2 mRNA yield in a single cultured embryonic lung.
This high sensitivity has advantages for limited sample ma- activate downstream genes remains to be elucidated (X.
Chen et al., 1996). Very recently, Smad7 was characterizedterial, as is the situation in mRNA measurement in embry-
onic tissues. The competitive PCR method developed as an antagonist of endogenous TGF-b signaling, by pre-
venting TGF-b-dependent formation of heteromeric Smadherein enabled us to measure Smad mRNA levels in a single
embryonic mouse lung without sample pooling. complexes, and inhibits the subsequent nuclear accumula-
tion (Hayashi et al., 1997; Topper et al., 1997). However,The TGF-b pathway is known to negatively regulate
branching morphogenesis of mammalian organs, and TGF-b activation of both TGF-b receptors and their intracellular
effector Smads is clearly required for TGF-b signaling tois a potent inhibitor of epithelial cell growth. Thus, several
components of TGF-b signaling pathways have been studied play a role in the negative regulation of lung branching
morphogenesis.as potential tumor suppressor genes. TGF-b type II receptor
mutations are found in human colon cancer cells (Marko- Smad proteins were detected mainly in the distal bron-
chial epithelium. Such localization patterns are reminiscentwitz et al., 1995) and probably permit the escape of these
cells from TGF-b-mediated negative growth control. Our of genes including BMPs, FGFs, HNF, and sonic hedgehog,
which have been shown to be important to the normal mor-previous studies showed that antisense ODN to TGF-b type
II receptor resulted in stimulation of lung branching and phogenesis of embryonic lung (Bellusci et al., 1996). Like
Smads, the above proteins have been detected in the epithe-prevented TGF-b-induced down-regulation of both cyclin
A and PCNA (Zhao et al., 1996), supporting the inhibitory lial tips of branching airways in embryonic lungs. Together
with the evidence that abrogation of Smad gene expressionrole of endogenous TGF-b signaling on embryonic organ
growth. Similarly, both missense and deletional somatic regulates embryonic lung branching, it is likely that Smad
gene expression regulates epithelial±mesenchymal interac-mutations of Smad were identi®ed in human lung cancer
and colorectal carcinoma (Uchida et al., 1996; Eppert et tion. Furthermore, while Smad proteins were found mainly
in the epithelial cytoplasm, the highest concentration ofal., 1996). Smad4 (DPC4), which associates with Smad1,
Smad2, or Smad3 in response to BMP, activin, or TGF-b, Smad proteins was observed lining the mesenchymal side
of the epithelium adjacent to the basement membrane. Suchrespectively, was initially isolated as a mutated gene in
human pancreatic carcinomas (Hahn et al., 1996; Schutte et a gradient pattern of Smad protein intracellular localization
further supports the notion that Smad genes function duringal., 1996). Such mutations in the Smad4 C-terminal domain
were later found to impair the heterometric interaction be- embryonic lung branching morphogenesis by transducing
endoderm±mesoderm interactions.tween Smad4 and other receptor-associated Smads (Wu et
al., 1997). Our ®nding that abrogation of Smad3 and Smad2 We conclude that endogenous TGF-b peptide signaling
through not only TGF-b receptors, but also Smads, exertsgenes resulted in stimulation of embryonic lung branching,
similar to abrogation of TGF-b type II receptor, indicates negative control of the process of early embryonic mouse
lung morphogenesis in culture. This negative regulation isthat both TGF-b receptors and the downstream Smads are
important mediators of the TGF-b pathway and thus partic- released by abrogation of endogenous Smad3, Smad2, or
Smad4 function using antisense ODN as an experimentalipate in TGF-b-mediated negative signaling.
Smad4 (DPC4) is a downstream mediator for both Smad3 approach. It is possible that these Smads, together with
TGF-b receptors and other downstream effector genes, or-and Smad2 (Lagna et al., 1996; Shi et al., 1997; Zhang et
al., 1997). Smad4 also serves as a partner for other Smads chestrate TGF-b-mediated gene regulation during embry-
onic lung organogenesis. We speculate that endogenousand associates with them. Thus, it is of biological signi®-
cance to test the role of Smad4 during embryonic lung TGF-b signaling through the Smads may serve to negatively
modulate and therefore balance the positive functions ofbranching morphogenesis. As we have shown in the current
study, Smad4, like TGF-b type II receptor or Smad3/2, also signaling by other peptide growth factor pathways, includ-
ing EGF, FGF, and PDGF, which exert positive inductivestimulated branching morphogenesis when Smad4 gene ex-
pression was inhibited by its antisense ODN in culture. and permissive in¯uences on lung morphogenesis.
But, addition of antisense ODN to both Smad3/2 and Smad4
simultaneously did not result in a synergistic effect upon
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